Related Experiment Video
Updated: May 16, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
LncRNA PGM5-AS1 regulates cell functions and acts as a potential biomarker to predict prognosis in breast cancer
Lei Xiang1, Yueqing Yin2, Linna Kong3
1Department of Oncology, The People's Hospital of Yizheng, China.
Abstract:
BackgroundThe aggressive proliferation and spread of breast cancer contributes to a dismal clinical outcome. The present study was to investigate the function and underlying mechanism of the long non-coding RNA (lncRNA) PGM5-AS1 in the modulation of breast cancer.MethodsQuantitative real time-polymerase chain reaction was utilized to assess the levels of PGM5-AS1 and miR-18a-3p. The prognostic significance was evaluated through Kaplan-Meier survival analysis and multivariate Cox regression analysis. Cell viability in breast cancer cells was measured utilizing a cell counting kit-8 kit. Cell migration and invasion were investigated using a transwell assay. The targeted regulatory interaction between PGM5-AS1, miR-18a-3p, and TGFBR3 was validated via dual luciferase reporter gene assay.ResultLevels of PGM5-AS1 were low in both breast tissue and cancer cell lines. This reduction in expression was linked to various clinical characteristics and a reduced overall survival rate in breast cancer patients. Upregulation of PGM5-AS1 expression noticeably inhibited proliferation, migration, and invasion in breast cancer cells. PGM5-AS1 regulated breast cancer development by controlling the miR-18a-3p/TGFBR3 axis.ConclusionThe lncRNA PGM5-AS1/miR-18a-3p/TGFBR3 axis is considered a potential genetic target for the development of breast cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Abnormal Proliferation
The Nucleolus

